Cequent pharmaceuticals, Inc.: The biological pitcher for RNAi therapeutics

Pharmacogenomics

Volumn 8, Issue 7, 2007, Pages 867-871

  Keetes, Andrew C ^a   Fruehauf, Johannes H ^a,b   Xiang, Shuanglin ^a   Parker, Peter D ^b   Li, Chiang J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Cequent Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CEQ 501; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ARTICLE; BACTERIUM; COLON CANCER; DRUG INDICATION; DRUG INDUSTRY; GASTROINTESTINAL TRACT; GENE INDUCTION; GENE SILENCING; GENE TARGETING; GENE TECHNOLOGY; HUMAN; RNA INTERFERENCE; TARGET CELL;

ADENOMATOUS POLYPOSIS COLI; BOSTON; DRUG INDUSTRY; GENE THERAPY; HUMANS; RNA INTERFERENCE;

EID: 34548095325     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.7.867     Document Type: Article

References (1)

1. Xiang S, Fruehauf J, Li CJ: Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat. Biotechnol. 24(6), 697-702 (2006).